Scientists have identified a molecular intermediate of a serotonin receptor that is involved in diseases such as depression and schizophrenia. The study points to a potentially new target for therapeutics.
A new drug target for psychiatric disorders
- Post author:
- Post published:September 5, 2024
- Post category:News Feed
- Post comments:0 Comments